Very good news from AcuCort AB

AcuCort AB has just now released news regarding signing a LOI with the global pharmaceutical company Glenmark Pharmaceuticals. The LOI covers the distribution and marketing of AcuCort's product Zeqmelit® in six European countries: Germany, the Netherlands, the Czech Republic, Austria, Slovakia, and Ukraine

Due to our CEO Jan Poulsen being a member of the board in AcuCort AB, we refrain from commenting further on this news but refer to the company's press release here.